ASIA-话题@MedSci - 梅斯（MedSci）

#ASIA#

71篇内容 | 1986人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1780101, encodeId=0fbd1e801019a, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：皮刺测试阴性慢性鼻炎患者屋尘螨局部过敏性鼻炎患病率研究, objectType=article, longId=163952, objectId=950d163952a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=950d163952a3, replyNumber=0, likeNumber=72, createdTime=2019-05-11, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=950d163952a3, moduleTitle=Asian Pac J Allergy Immunol：皮刺测试阴性慢性鼻炎患者屋尘螨局部过敏性鼻炎患病率研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=950d163952a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780105, encodeId=e5a31e801050d, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：哈达瑜伽对鼻炎症状和细胞因子的影响研究, objectType=article, longId=178374, objectId=b74d1e8374d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b74d1e8374d8, replyNumber=0, likeNumber=72, createdTime=2020-05-09, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b74d1e8374d8, moduleTitle=Asian Pac J Allergy Immunol：哈达瑜伽对鼻炎症状和细胞因子的影响研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b74d1e8374d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780102, encodeId=def21e80102cd, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：盐水洗鼻对儿童过敏性鼻炎和哮喘益处研究, objectType=article, longId=165914, objectId=ca23165914d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca23165914d4, replyNumber=0, likeNumber=97, createdTime=2019-12-03, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca23165914d4, moduleTitle=Asian Pac J Allergy Immunol：盐水洗鼻对儿童过敏性鼻炎和哮喘益处研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca23165914d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780106, encodeId=3f521e8010602, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间, objectType=article, longId=183719, objectId=f1bc183e1902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1bc183e1902, replyNumber=0, likeNumber=84, createdTime=2020-04-13, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1bc183e1902, moduleTitle=2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f1bc183e1902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780099, encodeId=65541e80099c0, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：中国过敏性鼻炎与哮喘并发流行度分析, objectType=article, longId=156721, objectId=12c2156e215f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12c2156e215f, replyNumber=0, likeNumber=75, createdTime=2019-10-07, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12c2156e215f, moduleTitle=Asian Pac J Allergy Immunol：中国过敏性鼻炎与哮喘并发流行度分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=12c2156e215f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780097, encodeId=4e551e8009741, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【2018 ESMO ASIA】SOLO1研究：BRCA突变卵巢癌患者一线维持治疗结果喜人, objectType=article, longId=154850, objectId=6a581548506d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a581548506d, replyNumber=0, likeNumber=88, createdTime=2019-09-12, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a581548506d, moduleTitle=【2018 ESMO ASIA】SOLO1研究：BRCA突变卵巢癌患者一线维持治疗结果喜人, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6a581548506d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780096, encodeId=87f41e8009699, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：有氧训练和维生素C补充对过敏性鼻炎患者鼻炎症状的影响研究, objectType=article, longId=147215, objectId=a83314e21552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a83314e21552, replyNumber=0, likeNumber=91, createdTime=2019-08-07, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a83314e21552, moduleTitle=Asian Pac J Allergy Immunol：有氧训练和维生素C补充对过敏性鼻炎患者鼻炎症状的影响研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a83314e21552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780095, encodeId=ffbc1e80095ac, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：在中度到重度屋尘螨敏感过敏性鼻炎患者中，CD4+末端分化效应记忆T细胞减少, objectType=article, longId=145187, objectId=3c2514518ef4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c2514518ef4, replyNumber=0, likeNumber=62, createdTime=2019-06-09, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c2514518ef4, moduleTitle=Asian Pac J Allergy Immunol：在中度到重度屋尘螨敏感过敏性鼻炎患者中，CD4+末端分化效应记忆T细胞减少, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3c2514518ef4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780098, encodeId=bb921e8009879, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：自备的高渗盐水鼻腔冲洗对过敏性鼻炎的效果研究, objectType=article, longId=156642, objectId=db22156642f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db22156642f9, replyNumber=0, likeNumber=69, createdTime=2019-06-12, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db22156642f9, moduleTitle=Asian Pac J Allergy Immunol：自备的高渗盐水鼻腔冲洗对过敏性鼻炎的效果研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=db22156642f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780094, encodeId=f1d61e800948c, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asia Pac J Ophthalmol (Phila)：针对小儿眼科医生的视网膜母细胞瘤综述, objectType=article, longId=138357, objectId=192213835e64, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=192213835e64, replyNumber=0, likeNumber=60, createdTime=2018-05-25, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=192213835e64, moduleTitle=Asia Pac J Ophthalmol (Phila)：针对小儿眼科医生的视网膜母细胞瘤综述, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=192213835e64)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780091, encodeId=c30e1e800918a, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：过敏性鼻炎的空气净化器治疗效果研究, objectType=article, longId=133736, objectId=40c8133e3642, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40c8133e3642, replyNumber=0, likeNumber=66, createdTime=2018-04-20, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40c8133e3642, moduleTitle=Asian Pac J Allergy Immunol：过敏性鼻炎的空气净化器治疗效果研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=40c8133e3642)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780078, encodeId=1f861e8007885, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asia Pac Allergy：2016年墨尔本风暴性哮喘流行分析：哮喘、鼻炎和其他过敏症, objectType=article, longId=119617, objectId=e1cf11961ef9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1cf11961ef9, replyNumber=0, likeNumber=70, createdTime=2018-03-26, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1cf11961ef9, moduleTitle=Asia Pac Allergy：2016年墨尔本风暴性哮喘流行分析：哮喘、鼻炎和其他过敏症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e1cf11961ef9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780087, encodeId=475b1e800876d, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【2017 ESMO ASIA】内外科专家共同讨论转移性肾癌局部治疗, objectType=article, longId=121064, objectId=acf812106476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acf812106476, replyNumber=0, likeNumber=44, createdTime=2018-02-04, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acf812106476, moduleTitle=【2017 ESMO ASIA】内外科专家共同讨论转移性肾癌局部治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=acf812106476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780079, encodeId=a82f1e80079cd, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Alcami宣布与Solasia达成原料药darinaparsin生产协议, objectType=article, longId=120312, objectId=49a91203122c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49a91203122c, replyNumber=0, likeNumber=66, createdTime=2017-12-10, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49a91203122c, moduleTitle=Alcami宣布与Solasia达成原料药darinaparsin生产协议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=49a91203122c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780084, encodeId=3b301e800842b, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【ESMO Asia】PACIFIC研究：Durvalumab显著延长局部晚期NSCLC的PFS, objectType=article, longId=120733, objectId=d89c120e33b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d89c120e33b7, replyNumber=0, likeNumber=66, createdTime=2018-06-03, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d89c120e33b7, moduleTitle=【ESMO Asia】PACIFIC研究：Durvalumab显著延长局部晚期NSCLC的PFS, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d89c120e33b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780089, encodeId=6a451e8008925, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Circ Cardiovasc Qual Outcomes：ASIAN-HF注册研究：中国仅17.9%需要植入ICD的心衰患者获得治疗, objectType=article, longId=121516, objectId=02351215168a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02351215168a, replyNumber=0, likeNumber=69, createdTime=2018-06-02, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02351215168a, moduleTitle=Circ Cardiovasc Qual Outcomes：ASIAN-HF注册研究：中国仅17.9%需要植入ICD的心衰患者获得治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02351215168a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780086, encodeId=4dd71e80086a5, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=2017 ESMO Asia AXEPT研究结果公布, objectType=article, longId=120916, objectId=607512091624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=607512091624, replyNumber=0, likeNumber=75, createdTime=2018-05-23, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=607512091624, moduleTitle=2017 ESMO Asia AXEPT研究结果公布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=607512091624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780075, encodeId=ece91e800751d, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=NPG Asia Materials：二维纳米材料肿瘤靶向放疗研究获进展, objectType=article, longId=119362, objectId=365d11936257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=365d11936257, replyNumber=0, likeNumber=74, createdTime=2018-10-21, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=365d11936257, moduleTitle=NPG Asia Materials：二维纳米材料肿瘤靶向放疗研究获进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=365d11936257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780081, encodeId=5e9b1e8008125, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【ESMO Asia 2017】舒尼替尼的个体化治疗, objectType=article, longId=120685, objectId=11cb12068513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11cb12068513, replyNumber=0, likeNumber=77, createdTime=2018-05-09, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11cb12068513, moduleTitle=【ESMO Asia 2017】舒尼替尼的个体化治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=11cb12068513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780074, encodeId=9cb51e8007464, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asia Pac Allergy：患有慢性阻塞性肺病和上呼吸道相关症状印度病人1型过敏反应的频率和影响研究, objectType=article, longId=119348, objectId=d52f119348fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d52f119348fc, replyNumber=0, likeNumber=63, createdTime=2018-01-26, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d52f119348fc, moduleTitle=Asia Pac Allergy：患有慢性阻塞性肺病和上呼吸道相关症状印度病人1型过敏反应的频率和影响研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d52f119348fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASIA

2020-05-29

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：皮刺测试阴性慢性鼻炎患者屋尘螨局部过敏性鼻炎患病率研究

2019-05-11

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：哈达瑜伽对鼻炎症状和细胞因子的影响研究

2020-05-09

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：盐水洗鼻对儿童过敏性鼻炎和哮喘益处研究

2019-12-03

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间

2020-04-13

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：中国过敏性鼻炎与哮喘并发流行度分析

2019-10-07

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【2018 ESMO ASIA】SOLO1研究：BRCA突变卵巢癌患者一线维持治疗结果喜人

2019-09-12

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：有氧训练和维生素C补充对过敏性鼻炎患者鼻炎症状的影响研究

2019-08-07

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：在中度到重度屋尘螨敏感过敏性鼻炎患者中，CD4+末端分化效应记忆T细胞减少

2019-06-09

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：自备的高渗盐水鼻腔冲洗对过敏性鼻炎的效果研究

2019-06-12

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asia Pac J Ophthalmol (Phila)：针对小儿眼科医生的视网膜母细胞瘤综述

2018-05-25

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：过敏性鼻炎的空气净化器治疗效果研究

2018-04-20

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asia Pac Allergy：2016年墨尔本风暴性哮喘流行分析：哮喘、鼻炎和其他过敏症

2018-03-26

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【2017 ESMO ASIA】内外科专家共同讨论转移性肾癌局部治疗

2018-02-04

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Alcami宣布与Solasia达成原料药darinaparsin生产协议

2017-12-10

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【ESMO Asia】PACIFIC研究：Durvalumab显著延长局部晚期NSCLC的PFS

2018-06-03

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Circ Cardiovasc Qual Outcomes：ASIAN-HF注册研究：中国仅17.9%需要植入ICD的心衰患者获得治疗

2018-06-02

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

2017 ESMO Asia AXEPT研究结果公布

2018-05-23

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

NPG Asia Materials：二维纳米材料肿瘤靶向放疗研究获进展

2018-10-21

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【ESMO Asia 2017】舒尼替尼的个体化治疗

2018-05-09

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asia Pac Allergy：患有慢性阻塞性肺病和上呼吸道相关症状印度病人1型过敏反应的频率和影响研究

2018-01-26

科室
- - 订阅+
  - 更多科室
工具
服务